Kenvue includes Johnson & Johnson brands Tylenol, Listerine, Neutrogena and Nicorette in its portfolio. The financial terms of the transaction were not disclosed; however, proceeds from the sale will go to Johnson & Johnson.
The company had a net income of $1.7 billion for the nine-month period ending Oct. 2.
